Please note: Forest Laboratories, Inc. is not responsible for
the content or services on the site you will now visit.
TEFLARO®: Proven Effective in Community-Acquired Bacterial Pneumonia (CABP)
Caused by Susceptible Bacteria
These hypothetical case studies present examples of types of patients who may benefit from TEFLARO.
*TEFLARO is indicated for ABSSSI due to MRSA. It is not indicated for CABP due to MRSA. MSSA=Methicillin-susceptible Staphylococcus aureus. MRSA=Methicillin-resistant Staphylococcus aureus. *There are insufficient historical data to establish the magnitude of drug effect for antibacterial drugs compared with placebo at a TOC time point. Etest® is a registered trademark of BioMérieux §MSSA=Methicillin-susceptible Staphylococcus aureus. Clinical efficacy of TEFLARO in treating CABP due to MRSA has not been studied.